Evidence map›Paper›PMID 29685457›Full record

ArticleThe Lancet. Infectious diseases2018

Drug-resistant tuberculosis: the rise of the monos.

Ebrahim Variava, Neil Martinson

Abstract readComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  7. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ebrahim VariavaDepartment of Internal Medicine, University of the Witwatersrand, and North West Province Department of Health, University of the Witwatersrand Johannesburg and Johns Hopkins University Center for TB Research, Baltimore, USA. Electronic address: variava@worldonline.co.za.
Neil MartinsonPerinatal HIV Research Unit (PHRU), SA MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, University of the Witwatersrand Johannesburg and Johns Hopkins University Center for TB Research, Baltimore, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cross-Sectional StudiesHumansPrevalenceResins, SyntheticSouth AfricaSurveys and QuestionnairesTuberculosis, Multidrug-ResistantMono-SResins, Synthetic

Identifiers

PMID29685457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.